Skip to main content
Top
Published in: Systematic Reviews 1/2019

Open Access 01-12-2019 | Hyperglycemia | Protocol

The role of innate lymphoid cells and T helper cell activation in type 2 diabetic patients: a protocol for a systematic review and meta-analysis

Authors: Vuyolwethu Mxinwa, Tawanda M. Nyambuya, Phiwayinkosi V. Dludla, Bongani B. Nkambule

Published in: Systematic Reviews | Issue 1/2019

Login to get access

Abstract

Background

Persistent levels of low-grade inflammation and T lymphocyte activation are associated with insulin resistance and type 2 diabetes that eventually lead to the development of cardiovascular diseases. Interestingly, increasing studies report on an emerging role of innate lymphoid cells in the development of both type 2 diabetes and cardiovascular disease. This systematic review will provide a comprehensive synthesis of available studies reporting on the role of innate lymphoid cells and associated T helper cell function in type 2 diabetic patients. It will further provide insight into the association of innate lymphoid cell activation and cardiovascular risk in adults living with type 2 diabetes.

Methods

This systematic review protocol has been prepared in accordance with Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols 2015 guidelines. The protocol has been registered with PROSPERO (CRD42018106159). This systematic review and meta-analysis will include published randomised clinical trials, observational studies, and case-control studies. We will also include grey literature. A search strategy will be developed with the help of subject librarian using Medical Subject Heading (MeSH) words for MEDLINE. This will then be adapted for the Embase database. Two independent reviewers VM and BBN will screen all studies using prespecified inclusion and exclusion criteria. The Downs and Black checklist will be used to assess the quality of individual studies. Predefined relevant data items will be extracted using sheets, and all study tables will be created using Review Manager V.5.3. The Grading of Recommendations Assessment, Development and Evaluation approach will be used to assess the strength of evidence.

Ethics and dissemination

The review will include publicly available data. The findings of this review will be disseminated through publications.
Literature
3.
go back to reference Patel PS, Buras EDBA. The role of the immune system in obesity and insulin resistance. J Obes. 2013;2013:1–9. Patel PS, Buras EDBA. The role of the immune system in obesity and insulin resistance. J Obes. 2013;2013:1–9.
6.
go back to reference Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne). 2016;7:APR):1–16.CrossRef Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne). 2016;7:APR):1–16.CrossRef
7.
go back to reference Cautivo KM, Molofsky AB. Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells. Eur J Immunogenet. 2016;46:1315–25.PubMedPubMedCentralCrossRef Cautivo KM, Molofsky AB. Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells. Eur J Immunogenet. 2016;46:1315–25.PubMedPubMedCentralCrossRef
8.
go back to reference Lu P, Ji X, Wan J, Xu H. Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy. 2017;99–107. Lu P, Ji X, Wan J, Xu H. Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy. 2017;99–107.
9.
go back to reference F Q, Wang H, Feng W, Ye X, Sun X, Jiang C, et al. ScienceDirect type 1 innate lymphoid cells are associated with type 2 diabetes. 2018;6–11. F Q, Wang H, Feng W, Ye X, Sun X, Jiang C, et al. ScienceDirect type 1 innate lymphoid cells are associated with type 2 diabetes. 2018;6–11.
11.
go back to reference Margetic S. Review inflammation and. Haemostasis. 2012;22(1):49–62. Margetic S. Review inflammation and. Haemostasis. 2012;22(1):49–62.
13.
go back to reference Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, et al. IL-25 Induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15(6):985–95.PubMedCrossRef Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, et al. IL-25 Induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15(6):985–95.PubMedCrossRef
15.
go back to reference Mjösberg JM, Trifari S, Crellin NK, Peters CP, Drunen CM Van, Piet B, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. 2011;12(11). Mjösberg JM, Trifari S, Crellin NK, Peters CP, Drunen CM Van, Piet B, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. 2011;12(11).
16.
go back to reference Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. 1998;377–384. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. 1998;377–384.
17.
go back to reference Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. 2003;327(7414):557–60.CrossRef Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. 2003;327(7414):557–60.CrossRef
18.
go back to reference Schroll JB, Moustgaard R, Gøtzsche PC. Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study. 2011; Schroll JB, Moustgaard R, Gøtzsche PC. Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study. 2011;
20.
go back to reference Nyambuya TM, Dludla PV, Nkambule BB. T cell activation and cardiovascular risk in type 2 diabetes mellitus: a protocol for a systematic review and meta-analysis. Syst Rev. 2018;7(1):1–6.CrossRef Nyambuya TM, Dludla PV, Nkambule BB. T cell activation and cardiovascular risk in type 2 diabetes mellitus: a protocol for a systematic review and meta-analysis. Syst Rev. 2018;7(1):1–6.CrossRef
Metadata
Title
The role of innate lymphoid cells and T helper cell activation in type 2 diabetic patients: a protocol for a systematic review and meta-analysis
Authors
Vuyolwethu Mxinwa
Tawanda M. Nyambuya
Phiwayinkosi V. Dludla
Bongani B. Nkambule
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2019
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-019-1144-z

Other articles of this Issue 1/2019

Systematic Reviews 1/2019 Go to the issue